Kudłacik-Kramarczyk Sonia, Drabczyk Anna, Głąb Magdalena, Gajda Paweł, Czopek Anna, Zagórska Agnieszka, Jaromin Anna, Gubernator Jerzy, Makara Agnieszka, Tyliszczak Bożena
Department of Materials Science, Faculty of Materials Engineering and Physics, Cracow University of Technology, 37 Jana Pawła II Av., 31-864 Krakow, Poland.
Department of Sustainable Energy Development, Faculty of Energy and Fuels, AGH University of Science and Technology, 30 Mickiewicza Av., 30-059 Krakow, Poland.
Materials (Basel). 2021 Aug 5;14(16):4386. doi: 10.3390/ma14164386.
Many studies are being performed to develop effective carriers for controlled cytostatic delivery wherein albumin is a promising material due to its tendency to accumulate near cancer cells. The novelty of this work involves the development of the synthesis methodology of albumin nanoparticles and their biological and physicochemical evaluation. Albumin particles were obtained via the salt-induced precipitation and KPO was used as a salting-out agent. Various concentrations of protein and salting-out agent solutions were mixed using a burette or a syringe system. It was proved that the size of the particles depended on the concentrations of the reagents and the methodology applied. As a result of a process performed using a burette and 2 M KPO, albumin spheres having a size 5-25 nm were obtained. The size of nanospheres and their spherical shape was confirmed via TEM analysis. The use of a syringe system led to preparation of particles of large polydispersity. The highest albumin concentration allowing for synthesis of homogeneous particles was 2 g/L. The presence of albumin in spheres was confirmed via the FT-IR technique and UV-Vis spectroscopy. All samples showed no cytotoxicity towards normal human dermal fibroblasts and no hemolytic properties against human erythrocytes (the hemolysis did not exceed 2.5%).
目前正在进行许多研究以开发用于控制细胞抑制药物递送的有效载体,其中白蛋白因其倾向于在癌细胞附近积累而成为一种有前景的材料。这项工作的新颖之处在于白蛋白纳米颗粒合成方法的开发及其生物学和物理化学评估。通过盐诱导沉淀获得白蛋白颗粒,并使用KPO作为盐析剂。使用滴定管或注射器系统混合不同浓度的蛋白质和盐析剂溶液。结果表明,颗粒的大小取决于试剂浓度和所应用的方法。使用滴定管和2 M KPO进行该过程的结果是获得了尺寸为5 - 25 nm的白蛋白球。通过透射电子显微镜(TEM)分析证实了纳米球的尺寸及其球形形状。使用注射器系统导致制备出多分散性大的颗粒。允许合成均匀颗粒的最高白蛋白浓度为2 g/L。通过傅里叶变换红外光谱(FT-IR)技术和紫外可见光谱证实了球中白蛋白的存在。所有样品对正常人皮肤成纤维细胞均无细胞毒性,对人红细胞也无溶血特性(溶血率不超过2.5%)。